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Abstract
Background: Trait heterogeneity, which exists when a trait has been defined with insufficient specificity
such that it is actually two or more distinct traits, has been implicated as a confounding factor in traditional
statistical genetics of complex human disease. In the absence of detailed phenotypic data collected
consistently in combination with genetic data, unsupervised computational methodologies offer the
potential for discovering underlying trait heterogeneity. The performance of three such methods –
Bayesian Classification, Hypergraph-Based Clustering, and Fuzzy k-Modes Clustering – appropriate for
categorical data were compared. Also tested was the ability of these methods to detect trait heterogeneity
in the presence of locus heterogeneity and/or gene-gene interaction, which are two other complicating
factors in discovering genetic models of complex human disease. To determine the efficacy of applying the
Bayesian Classification method to real data, the reliability of its internal clustering metrics at finding good
clusterings was evaluated using permutation testing.
Results: Bayesian Classification outperformed the other two methods, with the exception that the Fuzzy
k-Modes Clustering performed best on the most complex genetic model. Bayesian Classification achieved
excellent recovery for 75% of the datasets simulated under the simplest genetic model, while it achieved
moderate recovery for 56% of datasets with a sample size of 500 or more (across all simulated models)
and for 86% of datasets with 10 or fewer nonfunctional loci (across all simulated models). Neither
Hypergraph Clustering nor Fuzzy k-Modes Clustering achieved good or excellent cluster recovery for a
majority of datasets even under a restricted set of conditions. When using the average log of class strength
as the internal clustering metric, the false positive rate was controlled very well, at three percent or less
for all three significance levels (0.01, 0.05, 0.10), and the false negative rate was acceptably low (18 percent)
for the least stringent significance level of 0.10.
Conclusion:  Bayesian Classification shows promise as an unsupervised computational method for
dissecting trait heterogeneity in genotypic data. Its control of false positive and false negative rates lends
confidence to the validity of its results. Further investigation of how different parameter settings may
improve the performance of Bayesian Classification, especially under more complex genetic models, is
ongoing.
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Background
Complex human genetic disease
Molecular biologists and geneticists alike now acknowl-
edge that the most common human diseases with a
genetic component are likely to have very complex etiolo-
gies, involving such complicating factors as locus hetero-
geneity, trait heterogeneity, and gene-gene interactions
(Figure 1; [1-19]). However, only a small fraction of the
human genetics literature specifically reports on investiga-
tions of such complexity. Statistical geneticists continue
primarily using traditional methodologies, such as link-
age and association, which often detect but fail to repli-
cate findings of main effect genes. While undoubtedly
many of the original positive results are false-positives,
true effects may not be replicated for many reasons,
including population stratification and true differences in
genetic etiology between study populations [20].
Current statistical approaches to detecting heterogeneity,
such as the admixture test [21,22], are neither sensitive
nor powerful and can merely account for, not resolve, any
underlying heterogeneity. In addition, while a small
number of supervised computational methods exist for
discovering gene-gene interactions, the power of these
methods drops dramatically when locus or trait heteroge-
neity is present [23,24]. Phenotypic data can be utilized to
improve the performance of these methods in the face of
locus or trait heterogeneity by facilitating heuristic stratifi-
cation of data. However, for many diseases, little detailed
phenotypic data has been collected consistently in combi-
nation with genotypic data. It is for these reasons that an
unsupervised method, which does not rely on phenotypic
data, is needed to mine potentially heterogeneous geno-
typic data as a means of data stratification and hypothesis
generation.
For genetic factors involving heterogeneity, there are mul-
tiple independent (predictor) variables or else multiple
dependent (outcome) variables that complicate the anal-
ysis by creating a heterogeneous model landscape. In the
case of locus heterogeneity, multiple predictor variables
(i.e., multiple loci) are present, some of which may be
unmeasured or unobserved and, therefore, unavailable
Factors Complicating Analysis of Complex Genetic Disease: Definitions, Diagrams and Examples Figure 1
Factors Complicating Analysis of Complex Genetic Disease: Definitions, Diagrams and Examples
Creutzfeldt-Jakob Disease (CJD, OMIM# 
123400) and Fatal Familial Insomnia 
(OMIM# 176640.0010) - the Met129Val 
polymorphism and Asp178Asn mutation in 
the PRNP gene (OMIM# 176640) interact, 
such that when the val129 polymorphism 
is on the same chromosome as the 
asn178, the phenotype is fatal familial 
insomnia 13-19
Autism (OMIM# 209850) - parents and other 
relatives of autistic individuals often exhibit 
one or two, but not all three, of the requisite 
autistic symptomatologies, suggesting 
autism may be the co-occurrence of three 
distinct traits.9 Using subset analysis, some 
success has been achieved identifying 
genes associated with one of the three 
symptomatologies but not as strongly with 
the broader autistic phenotype10,11
Tuberous Sclerosis (TS, OMIM# 
191100) - out of families informative for 
linkage analysis, half have mutations in 
the TSC1 gene (located at 9q34) and 
the other half have mutations in the 
TSC2 gene (located at 16p13)3,4,5
Example 
Two
Hirschsprung Disease (OMIM# 142623) -
variants in the RET (OMIM# 164761) and 
EDNRB (OMIM# 131244) genes have 
been shown to interact synergistically such 
that they increase disease risk far beyond 
the combined risk of the independent 
variants12
Autosomal Dominant Cerebellar Ataxia
(ADCA, OMIM# 164500) - originally 
described as a single disease, three different 
clinical subtypes have been defined based 
on variable associated symptoms,6,7 and 
different genetic loci have been associated 
with the different subtypes8
Retinitis Pigmentosa (RP, OMIM# 
268000) - genetic variations in at least 
fifteen genes have been associated 
with RP under an autosomal recessive 
model.  Still more have been 
associated with RP under autosomal 
dominant and X-linked disease 
models2
(http://www.sph.uth.tmc.edu/RetNet)
Example 
One
Diagram
when two or more DNA variations interact 
either directly (DNA-DNA or DNA-mRNA 
interactions), to change transcription or 
translation levels, or indirectly by way of 
their protein products, to alter disease risk 
separate from their independent effects
when a trait, or disease, has been defined 
with insufficient specificity such that it is 
actually two or more distinct underlying traits
when two or more DNA variations in 
distinct genetic loci are independently 
associated with the same trait
Definition
Gene-Gene Interaction Trait Heterogeneity Locus Heterogeneity
Allelic Variant i
Of Locus A
Allelic Variant ii
Of Locus B
Disease X
Allelic Variant i
Of Locus A
Allelic Variant ii
Of Locus B
No Disease Disease X
Trait I Trait II
Disease XBMC Bioinformatics 2006, 7:204 http://www.biomedcentral.com/1471-2105/7/204
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for inclusion in the disease model. In the case of trait het-
erogeneity, multiple outcome variables are present, which
cannot or have not been distinguished based on the avail-
able phenotypic information. Gene-gene interactions cre-
ate a rugged model landscape for statistical analysis. There
is clear and convincing evidence that gene-gene interac-
tions, whether synergistic or antagonistic, are not only
possible but probably ubiquitous [18,19,25-28]. Thus, it
is critical that complex genetic data sets be properly inter-
rogated for possible underlying interactions.
Statistical analysis
No one analytic method is superior in all respects for the
range of complicating factors that might be present in a
specific data set. Given the relative shortcomings of our
current analyses in complex diseases, we need to greatly
extend the range of available analytical tools. There is a
critical need for extensive reevaluation of existing meth-
odologies for complex diseases, as well as for massive
efforts in new method development. It is important that
empirical studies be conducted to compare and contrast
the relative strengths and weaknesses of methods on spe-
cific types of problems. For example, while cluster analysis
has shown promise in numerous scientific and mathe-
matical fields, including genetics [29,30], its use with dis-
crete genotypic data has not been adequately explored.
Similarly, artificial neural networks modified with evolu-
tionary computation have great potential for discovering
nonlinear interactions among genes and environmental
factors [31]. However, work is still ongoing to evaluate
their limitations with regard to the heritability and effect
sizes that can be detected.
Ultimately, though, the real power of existing and yet-to-
be-developed methods lies in our ability to marry them
into a comprehensive approach to genetic analysis, so that
their relative strengths and weaknesses can be balanced
and few alternative hypotheses are left uninvestigated.
Because no single method adequately investigates hetero-
geneity and interaction issues simultaneously, we propose
routinely taking a two-step approach to analysis. For
example, clustering or ordered subset analysis [32] can be
used first to uncover genotypic and/or phenotypic hetero-
geneity and to subdivide the data into more homogene-
ous groups. Then in a second step, specific tests of
interactions, such as the S sum statistic approach
[33,34,34] or the multifactor dimensionality reduction
method [23,24,35-37] could be used to investigate gene-
gene or gene-environment interactions within each of the
homogenized subgroups. While this is not a perfect
approach, it is an important improvement over the more
common alternative of a single-pronged approach to
analysis.
Cluster analysis
For over 30 years, cluster analysis has been used as a
method of data exploration [38]. Clustering is an unsu-
pervised classification methodology, which attempts to
uncover 'natural' clusters or partitions of data. It involves
data encoding and choosing a similarity metric, which
will be used in determining the relative 'goodness' of a
clustering of data. No one clustering method has been
shown universally effective when applied to the wide vari-
ety of structures present in multidimensional data sets.
Instead, the choice of suitable methods is dependent on
the type of target data to be analyzed. Clustering has been
utilized widely for the analysis of gene expression (e.g.,
DNA microarray) data; however, its application to geno-
typic data has been limited [29].
Most traditional clustering algorithms use a similarity
metric based on distance that may be inappropriate for
categorical data such as genotypes. Newer methods have
been developed with categorical data in mind and include
extensions of traditional methods and application of
probabilistic theory. Three such methods were chosen for
comparison in the task of discovering trait heterogeneity
using multilocus genotypes – Bayesian Classification [39],
Hypergraph-Based Clustering [40], and Fuzzy k-Modes
Clustering [41] – all of which are appropriate for categor-
ical data.
Results
Descriptive statistics
The Hubert-Arabie Adjusted Rand Index (ARIHA) was cho-
sen as the standard for measuring clustering result fitness
[42]. An ARIHA score of 0.90 indicates excellent cluster
recovery, 0.80 good recovery, and 0.65 moderate recovery.
Mean ARIHA values for Bayesian Classification, Hyper-
graph Clustering and Fuzzy k-Modes Clustering were
0.666, 0.354 and 0.556, respectively. Confidence intervals
around the means were also produced to demonstrate the
preciseness of the ARIHA measurements. The results for
each method across all datasets are presented in Table 1.
Mean ARIHA values differed by genetic model type (Figure
2), with higher scores achieved on Trait Heterogeneity
Only (THO) datasets for the Bayesian Classification and
Hypergraph Clustering methods (Figure 3).
Table 1: Confidence intervals around ARIHA means by method.
95% Confidence Interval
Method Mean Standard 
Error
Lower End Upper End
Bayesian 0.666 0.001 0.664 0.667
Hypergraph 0.354 0.001 0.352 0.355
Fuzzy k-Modes 0.556 0.001 0.555 0.558BMC Bioinformatics 2006, 7:204 http://www.biomedcentral.com/1471-2105/7/204
Page 4 of 18
(page number not for citation purposes)
Comparison of clustering methods
Three categorical variables were constructed that could be
tested using the nonparametric chi-square test of inde-
pendence. The three variables were calculated as the
number of clustering results achieving each of the three
ARIHA cutoff values of 0.90 (for excellent cluster recovery),
0.80 (for good cluster recovery) and 0.65 (for moderate
cluster recovery). Results are displayed as percentages by
clustering method (Figure 4) and by clustering method
and genetic model (Figure 5A). A chi-square test of inde-
pendence was performed testing the null hypothesis that
the number of clusterings achieving the specified ARIHA
cutoff value was independent of the clustering method.
The three methods performed significantly differently on
each of the ARIHA cutoff statistics (Table 2). Bayesian Clas-
sification outperformed the other two methods. However,
across all the dataset parameters, Bayesian Classification
achieved moderate or better recovery on only 48% of the
datasets (Figure 4).
The performance of the three clustering methods across
different dataset parameters was evaluated in an attempt
to find particular conditions under which one method
consistently achieved good or excellent recovery (not just
better recovery than the other two methods). For those
datasets simulated under the THO model, Bayesian Clas-
sification performed well, with over 73 percent of its
resulting clusterings achieving an ARIHA value of 0.90 or
greater, indicating excellent recovery (Figure 5). For this
subset of the datasets, Bayesian Classification outper-
formed the other two methods, and again there was a sig-
nificant difference in performance across the three
methods, as measured by a chi-square test of independ-
ence on each of the three new ARIHA cutoff statistics
(Table 3). Analysis of the other simulation parameters
failed to show as great a difference among methods where
the 'winning' method performed as well as the Bayesian
Classification performed in the THO datasets (data not
shown). Thus, this subset of data was chosen for further
investigation into the efficacy of using the Bayesian Clas-
sification method to uncover trait heterogeneity in real
data.
Applicability to real data
To evaluate the validity of using the Bayesian Classifica-
tion internal clustering metrics – class strength and cross-
class entropy – as a proxy for the ARIHA (since ARIHA is
unknown for real data), permutation testing was per-
formed. Resulting p-values for ARIHA, average log of class
strength and average cross class entropy were used to cal-
culate false positive and false negative rates at three signif-
icance levels of 0.01, 0.05 and 0.10. A clustering result was
considered a false positive if it was considered significant
according to either average log of class strength or average
cross class entropy but was not considered significant
according to our ARIHA standard. A clustering result was
considered a false negative if it was called not-significant
according to both average log of class strength and aver-
Comparison of ARIHA Means by Method and Model Figure 3
Comparison of ARIHA Means by Method and Model. 
Comparison of Hubert-Arabie Adjusted Rand Index means 
by method and model. Bars represent means, and error bars, 
which are very short and may be difficult to see, represent 
95% confidence intervals. Horizontal lines represent thresh-
olds for quality of cluster recovery: 0.90 for excellent recov-
ery, 0.80 for good recovery and 0.65 for moderate recovery.
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Structure of Genetic Models Used for Data Simulation Figure 2
Structure of Genetic Models Used for Data Simulation
Model 1 – Trait Heterogeneity Only 
        
Allelic Variant i of Locus A    DiseaseX-Associated Trait I 
           D i s e a s e   X  
Allelic Variant ii of Locus B    DiseaseX-Associated Trait II 
Model 2 – Trait Heterogeneity with Locus Heterogeneity 
Allelic Variant i of Locus A     
      DiseaseX-Associated  Trait  I   
Allelic  Variant  ii  of  Locus  B        Disease  X 
Allelic Variant iii of Locus C    DiseaseX-Associated Trait II 
Model 3 – Trait Heterogeneity with Gene-Gene Interaction 
Allelic Variant i of Locus A     
      DiseaseX-Associated  Trait  I   
Allelic  Variant  ii  of  Locus  B        Disease  X 
Allelic Variant iii of Locus C    DiseaseX-Associated Trait II 
Model 4 – Trait Heterogeneity with Locus Heterogeneity and
Gene-Gene Interaction 
Allelic Variant i of Locus A     
      DiseaseX-Associated  Trait  I   
Allelic  Variant  ii  of  Locus  B         
           D i s e a s e   X  
Allelic Variant iii of Locus C     
      DiseaseX-Associated  Trait  II   
Allelic Variant iv of Locus DBMC Bioinformatics 2006, 7:204 http://www.biomedcentral.com/1471-2105/7/204
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age cross class entropy but was considered significant
according to ARIHA. Figures 6 and 7 show the false positive
and false negative rates, respectively, by alpha level.
The false positive, or Type I, error rate was controlled very
well at three percent or less for all three significance levels.
The false negative, or Type II, error rate was not controlled
as well, however. At the least stringent significance level (α
= 0.10), the Type II error rate was 18 percent, and at the
most stringent level (α = 0.01), the rate was 47 percent.
Other simulation parameters were examined for their
impact on the false negative rate, and Figures 8 and 9
show the false negative rate by alpha level paneled by
number of nonfunctional loci and number of affecteds
(sample size), respectively. As might be expected, the low-
est false negative rates were achieved for datasets with the
lowest number of nonfunctional loci (10) and the greatest
sample size (1000).
Discussion
Data simulation
The new data simulation algorithm produced complex
genotypic datasets that included trait heterogeneity, locus
heterogeneity and gene-gene interactions. Most existing
simulation software that attempt to simulate heterogene-
ity do so by allowing the user to specify what portion of
the dataset is to be simulated under one model versus
another, and the resulting individuals are simply com-
bined into one dataset. In the new algorithm, however,
the disease penetrance models, which were used to simu-
late the data, were constructed so that overall prevalence
levels were controlled, allowing naturally occurring over-
laps, in which some individuals would have both traits
(and their associated multilocus genotypes) by chance.
This novel data simulation algorithm should prove very
useful for future studies of other proposed genetic analysis
methods for complex diseases.
Comparison of clustering methods
The Bayesian Classification method outperformed the
other two methods across most dataset parameter combi-
nations, with the exception of the most complex model
(THB) on which Fuzzy k-Modes Clustering performed
best. When the results were further examined to find a set
of parameters for which one or more methods performed
well, Bayesian Classification was found to have achieved
excellent recovery for 73% of the datasets with the THO
model and achieved moderate recovery for 56% of data-
sets with 500 or more affecteds and for 86% of datasets
with 10 or fewer nonfunctional loci (data not shown
here). Neither Hypergraph Clustering nor Fuzzy k-Modes
Clustering achieved good or excellent cluster recovery
even under a restricted set of conditions.
Bayesian Classification was obtained as closed-source
software, for which there were numerous parameters,
which could have been optimized. Initial parameter set-
tings were chosen as recommended by the authors based
on the type of data being analyzed. However, it is possible
that alternative settings may have yielded better results.
For example, for datasets with the more complex genetic
models, greater numbers of nonfunctional loci and
smaller sample sizes, the maximum number of classifica-
Table 3: Results of Chi-Square Test of Independence for Trait 
Heterogeneity Only datasets. Results of chi-square test of 
independence for Trait Heterogeneity Only datasets, testing the 
null hypothesis that the percentage of clustering results 
achieving the specified cluster recovery level does not differ 
across clustering methods.
Cluster Recovery Statistic Model χ2 df p
%Results achieving Excellent cluster 
recovery (ARIHA ≥ 0.90)
THO 3713 2 < 0.001
%Results achieving Good cluster 
recovery (ARIHA ≥ 0.80)
THO 3107 2 < 0.001
%Results achieving Moderate cluster 
recovery (ARIHA ≥ 0.65)
THO 2609 2 < 0.001
Percentage of Clustering Results Achieving Cluster Recovery  Levels by Method Figure 4
Percentage of Clustering Results Achieving Cluster Recovery 
Levels by Method
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Table 2: Overall results of Chi-Square Test of Independence. 
Overall results of chi-square test of independence testing the null 
hypothesis that the percentage of clustering results achieving the 
specified cluster recovery level does not differ across clustering 
methods.
Cluster Recovery Statistic χ2 df p
%Results achieving Excellent cluster recovery 
(ARIHA ≥ 0.90)
1787 2 < 0.001
%Results achieving Good cluster recovery 
(ARIHA ≥ 0.80)
1614 2 < 0.001
%Results achieving Moderate cluster recovery 
(ARIHA ≥ 0.65)
8565 2 < 0.001BMC Bioinformatics 2006, 7:204 http://www.biomedcentral.com/1471-2105/7/204
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tion trials and/or the maximum number of classification
cycles per trial may need to be longer, and those parame-
ters concerned with convergence rate and stopping criteria
may need to be changed to delay convergence. If improve-
ments in performance could be achieved with reasonable
time and resource tradeoffs, such changes would certainly
be desirable. The results of this simulation study are
encouraging enough to warrant further investigation of
this matter.
It was disappointing that Hypergraph Clustering did not
perform very well under most conditions, despite its intu-
itive appeal as a method that would find frequently-occur-
ring multilocus genotypic patterns. The Hypergraph
Clustering method has been reported to work well with
very large variable sets (on the order of thousands), which
have complex patterns for which large numbers of clusters
(10–20+) were relevant [43]. However, there has been no
examination of the method's performance on smaller var-
iable sets. Thus, it is possible that the restricted patterns
present in our multilocus genotypic data were too simple
and sparse and that the method is simply tuned to search
for more complex patterns. Also, we were required to
devise a translation of the resulting partitioning of geno-
types into a clustering of individuals. We tested several
such translations and implemented the best process out of
several tested. Oftentimes, even when the method cor-
rectly chose the functional genotypes to be in different
partitions, too many other nonfunctional genotypes were
also chosen, which meant that the difference between an
individual's likelihood of belonging to one cluster versus
another was too small, making the choice of cluster
assignment almost arbitrary.
Percentage of Clustering Results Achieving Cluster Recovery Levels by Method and Model Figure 5
Percentage of Clustering Results Achieving Cluster Recovery Levels by Method and Model
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The Fuzzy k-Modes Clustering method performed compa-
rably to Bayesian Classification for the more complex
datasets and was much less computationally intensive. It
has been widely reported that the performance of k-means
algorithms is highly variable depending on the method of
seeding the initial cluster centroids [44]. While we used
the recommended method of selecting individuals from
the dataset to serve as the initial cluster modes, we per-
haps could have achieved better results if we implemented
an additional step to ensure that the initial centroids were
substantially dissimilar to each other. This is supported by
evidence that when the Fuzzy k-Modes Clustering resulted
in only one cluster (effectively no partitioning of the
data), the initial centroids were very similar and the
method had converged early so that individuals had equal
probability of belonging to any of the clusters. In such
cases, the individual was arbitrarily assigned to the first
cluster, thereby leading to all other clusters being empty.
As expected, the simpler the model, the better the per-
formance of the three clustering algorithms, with the
exception that the Hypergraph Clustering and Fuzzy k-
Modes Clustering methods performed somewhat better
on the THB (Trait Heterogeneity with Both locus hetero-
geneity and gene-gene interaction) datasets than they did
on the THL (Trait Heterogeneity with Locus heterogene-
ity) and THG (Trait Heterogeneity with Gene-gene inter-
action) datasets. Likewise, in general, the fewer the
nonfunctional loci and the larger the sample size, the bet-
ter the performance was.
Applicability to real data
To determine the efficacy of using the Bayesian Classifica-
tion method on real data, the reliability of its internal
clustering metrics at finding good clusterings was evalu-
ated. Using the combination of the average log of class
strength and the average cross class entropy to determine
significance, the false positive rate was controlled very
well, at three percent or less for all three significance lev-
els. The false negative rate was acceptably low (18 percent)
for the less stringent significance levels of 0.10. However,
it was high (47 percent) for the most stringent significance
level of 0.01. Thus, if a clustering of data were called sig-
nificant according to permutation testing using either the
average log of class strength or the average cross class
entropy, we can be quite confident that the result were
real. Typically geneticists prefer to accept a higher false
positive rate to increase power; however, there is indeed a
trade-off between these two types of error. Valuable time
and resources can be spent on follow-up studies, and it
can be very detrimental to pursue leads that do not have a
good chance of yielding new information about the dis-
ease under study.
Conclusion
The efficacy of three clustering methodologies at uncover-
ing trait heterogeneity in genotypic data was investigated.
One method, Bayesian Classification, was found to per-
form very well under certain conditions (THO model)
and to outperform the other methods. Permutation test-
ing confirmed that the method could be used on real data
with excellent Type I error control and acceptable Type II
error control. By controlling the false positive rate so well,
False Negative Rate by Significance Level (alpha) Figure 7
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False Positive Rate by Significance Level (alpha) Figure 6
False Positive Rate by Significance Level (alpha)
0.01 0.05 0.10
Alpha
0.00
0.10
0.20
0.30
0.40
0.50
F
a
l
s
e
P
o
s
i
t
i
v
e
R
a
t
e
0.00 0.02
0.03BMC Bioinformatics 2006, 7:204 http://www.biomedcentral.com/1471-2105/7/204
Page 8 of 18
(page number not for citation purposes)
Bayesian Classification offers a comfortable degree of cer-
tainty with regard to the hypotheses that it generates. This
is true at least when the underlying data structure is simi-
lar to that simulated under the THO model. Further inves-
tigation of how different parameter settings may improve
the performance of Bayesian Classification is planned.
Methods
Data simulation
To compare the performance of clustering methodologies
in the task of uncovering trait heterogeneity in genotypic
data, datasets were needed in which such heterogeneity
was known to exist. Since there are no well-characterized
real datasets available that fit this description, a simula-
tion study was needed. Genetic models that contained
two binary disease-associated traits, such that there is trait
heterogeneity among 'affected' individuals, were used. In
addition, some of the models incorporate locus heteroge-
neity, a gene-gene interaction, or both. Figure 2 depicts
the structure of the four genetic models used to simulate
the genotypic data.
Four prevalence levels were simulated for each genetic
model: (1) fifteen percent, which is characteristic of a
common disease phenotype such as obesity [45], (2) five
percent, which is characteristic of a relatively common
disease such as prostate cancer [46], (3) one percent,
which is characteristic of a less common disease such as
schizophrenia [47], and (4) one tenth of one percent,
which is characteristic of a more uncommon disease such
as multiple sclerosis [48]. Three realistic levels of sample
size were simulated for each model: 200, 500 and 1000
affected individuals. Finally, four levels of non-functional
loci were simulated: 0, 10, 50 and 100. The inclusion of
non-functional loci adds a random noise effect that is
present in real candidate gene studies in which the func-
tional locus or loci are among many more suspected but
actually non-functional loci. All loci, including the func-
tional loci, were simulated to have equal biallelic frequen-
cies of 0.5.
Although the above parameter settings are by no means
exhaustive of the biologically plausible situations, the
outlined conditions are reasonable and specify 192 differ-
ent sets of data specifications due to the combinatorial
nature of the study design. To have adequate power to
detect a difference in performance among clustering
methodologies, 100 datasets per set of parameters, result-
ing in a total of 19,200 simulated data sets, were simu-
lated.
For the purposes of simulating this data, a novel data sim-
ulation algorithm capable of incorporating these complex
genetic factors in an epidemiologically-sound manner
was designed and developed (Figure 10). Penetrance is the
False Negative Rate by Significance Level (alpha) Paneled by  Number of Nonfunctional Loci Figure 8
False Negative Rate by Significance Level (alpha) Paneled by 
Number of Nonfunctional Loci
0.00
0.20
0.40
0.60
0.80
1.00
F
a
l
s
e
N
e
g
a
t
i
v
e
R
a
t
e
0.23
0.01
10
50
100
0.00
0.20
0.40
0.60
0.80
1.00
F
a
l
s
e
N
e
g
a
t
i
v
e
R
a
t
e
0.76
0.40
0.23
0.01 0.05 0.10
Alp ha
0.00
0.20
0.40
0.60
0.80
1.00
F
a
l
s
e
N
e
g
a
t
i
v
e
R
a
t
e
0.41
0.35 0.32BMC Bioinformatics 2006, 7:204 http://www.biomedcentral.com/1471-2105/7/204
Page 9 of 18
(page number not for citation purposes)
probability of having a particular trait given a specific gen-
otype (single or multilocus). Prevalence, on the other
hand, is the percentage of individuals in a population that
have a particular trait. The penetrance levels of the two
simulated disease-associated traits are constrained by the
overall prevalence level of the simulated disease. The two
traits were simulated to contribute equally to the preva-
lence of the associated disease (fifty percent trait heteroge-
neity), such that a small but naturally occurring degree of
overlap would be present, representing individuals having
both disease-associated traits, instead of just one or the
other. These penetrance tables are inputs for the new data
simulation algorithm.
For one fourth of the models, trait heterogeneity only is
involved (not locus heterogeneity or gene-gene interac-
tions), and there is one genetic risk factor for each of the
two traits. Each locus acts in a recessive manner, such that
affected individuals have both copies of the high-risk
allele at the disease-associated "functional" locus (Figure
11). A naturally occurring degree of overlap between the
two traits can result, such that some affected individuals
have the high-risk genotypes for both traits.
In the second quarter of the datasets, alocus heterogeneity
described by Li and Reich [49] was also simulated (Figure
12(II)) so that for one of the traits, there are two associ-
ated loci, each of which is responsible for roughly half of
the individuals affected with the trait. In that locus heter-
ogeneity model, each of the functional loci acts in a reces-
sive manner, such that the disease-associated genotype for
the locus consists of two copies of the high-risk allele. For
the other trait, a recessive model was implemented, as
described above (Figure 12(I)). By chance, there might be
some affected individuals who have the high-risk geno-
type from the first trait as well as one of the high-risk gen-
otypes from the second trait.
In the third quarter of the datasets, a gene-gene interaction
was simulated for one of the two traits. The "diagonal"
gene-gene interaction model, first described by Frankel
and Schork [50] and later by Li and Reich[49], which is
nonlinear and nonadditive in nature, was used (Figure
13(II)). Under this model, a multilocus genotype is high-
risk if it has exactly two high-risk alleles from either of the
two associated loci. A multilocus genotype with fewer
than or greater than two high-risk alleles is not associated
with disease. For the other trait, a recessive model was
implemented, as described above (Figure 13(I)). By
chance, there might be some affected individuals who
have the high-risk genotype from the first trait as well as
one of the high-risk genotypes from the second trait.
In the fourth quarter of the datasets, one trait is simulated
to involve locus heterogeneity (Figure 14(I)), while the
False Negative Rate by Significance Level (alpha) Paneled by  Number of Affecteds Figure 9
False Negative Rate by Significance Level (alpha) Paneled by 
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Novel Data Simulation Algorithm Figure 10
Novel Data Simulation Algorithm. Simulates trait heterogeneity, locus heterogeneity and gene-gene interactions in an epi-
demiologically-sound manner. The inputs are penetrance function arrays, which are translated into probability arrays for affect-
eds and unaffecteds, separately. Then affected and unaffected individuals (with multilocus genotypes) are simulated from those 
respective arrays.
Penetrance Function Array:  each cell value represents the probability of having the disease-
associated trait, given the (multilocus) genotype 
Unaffecteds Probability Array:  each cell value represents the probability of having the multilocus 
genotype given that the disease status is unaffected, which is the probability of being negative 
for all traits, or the joint probability of being negative for each trait, given the genotype 
frequency (prior probability) 
Affecteds Probability Array:  each cell value represents the probability of having the multilocus 
genotype given that the disease status is affected, which is the probability of being positive for 
at least one trait, which is the same as 1 – probability of being negative for all traits, or 1- joint 
probability of being negative for each trait, given the genotype frequency (prior probability) 
Pseudocode: 
1.  Allocate two probability arrays, one for Affecteds and one for Unaffecteds, each of size 
∏∑
L
i
A
j
i
j
1 1
  where L is the total number of loci and Ai is the number of alleles for locus i.
2.  For each penetrance function p(Status=Affected | Multilocus Genotype) 
==>Distribute 1-p across relevant cells of Unaffecteds probability array 
3.  Populate cells of the Affecteds probability array with 1-(cell probability) of corresponding cells of 
the Unaffecteds probability array 
4.  For each locus  
==>Distribute allele frequencies across appropriate cells of both probability arrays 
5.  Generate the specified number of unaffected individuals from the Unaffecteds probability array 
6.  Generate the specified number of affected individuals from the Affecteds probability array 
7.  Determine the status of each disease-associated trait for each affected individual thus….  If the 
affected individual has a high-risk genotype combination for that disease-associated trait, then 
that individual is affected for that trait.  Otherwise, the individual is unaffected for that disease-
associated trait.  (By design, each affected individual will be affected at one or more disease-
associated traits.) BMC Bioinformatics 2006, 7:204 http://www.biomedcentral.com/1471-2105/7/204
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other is simulated to involve the "diagonal" gene-gene
interaction, as described above (Figure 14(II)). Thus, there
are some affected individuals who, by chance, will have
one high-risk genotype from the first trait as well as one
high-risk genotype from the second trait.
The input file for each of the clustering methods described
below includes genotype and trait status information.
Each row is a single individual. Column headings include
unique individual number, trait status (affected for Trait
1, Trait 2, or both), and all simulated loci. Genotypes for
each locus are encoded nominally (not ordinally), such
that no genetic model assumptions are incorporated. Loci
are numbered, and alleles are lettered. Thus, for a given
locus '3' that has two alleles 'A' and 'B', the three possible
genotypes are '3A3A', '3A3B', and '3B3B'. A different
nomenclature could easily be used, however, since the
methods simply treat each genotype as a character string
for labeling purposes only and do not attribute any mean-
ing or order to them.
Clustering methods
There exists a very large number of clustering algorithms
and even more implementations of those algorithms. The
choice of which clustering methodology to use should be
determined by the kind of data being clustered and the
purpose of the clustering [51]. Genotypic data is categori-
cal, which immediately narrows the field of appropriate
methods for this study to only a few. Three different clus-
tering methodologies were chosen that are suitable for
categorical data and are appealing due to their speed or
theoretical underpinnings.
The goal of this clustering is to find a partitioning of the
affected individuals based on multilocus genotypic com-
binations that maps onto the trait heterogeneity simu-
lated in the data. For example, consider a dataset with 10
loci (numbered 1 to 10), each of which has two alleles (A
and B), such that at each locus there are three possible
genotypes (AA, AB and BB). It is likely that among affected
individuals in the dataset, subsets of individuals will share
specific genotypes or multilocus combinations of geno-
types (such as 2B2B; or 3A3B and 9A9B together), either
by chance or because such combinations are related to
genetic background, phenotypic variability, or trait heter-
ogeneity in some way. Thus, a successful clustering would
be one in which all the individuals who were simulated to
have Trait I end up in one or more clusters that do not
have any individuals unaffected for Trait I and all individ-
uals who were simulated to have Trait II end up in one or
more distinct clusters that do not have any individuals
unaffected for Trait II (Figure 15). (Those individuals,
who by chance have both Trait I and Trait II, could be 'cor-
rectly' placed in any cluster.) Such a clustering would
effectively eliminate the noise present among affected
individuals due to trait heterogeneity. In the case where
Genetic Model THL (Trait Heterogeneity with Locus Heter- ogeneity) Figure 12
Genetic Model THL (Trait Heterogeneity with Locus 
Heterogeneity). The penetrance tables for Trait I and Trait 
II are presented. Cell values indicate penetrance level, or the 
probability of having the trait, given the corresponding multi-
locus genotype. For Trait I, a Mendelian recessive genetic 
model is used, in which the trait is penetrant only when two 
copies of the high risk (B) allele are present. For Trait II, a 
locus heterogeneity model described by Li and Reich [49] is 
used, in which the trait is penetrant only when two copies of 
the high risk allele at one or both loci are present (in this 
case the B alleles for locus 2 and 3 are high risk).
 (I)  
1A1A 1A1B 1B1B
0 0 x 
(II)  
 2A2A 2A2B 2B2B
3A3A 0 0 x 
3A3B 0 0 x 
3B3B x x x  Genetic Model THO (Trait Heterogeneity Only) Figure 11
Genetic Model THO (Trait Heterogeneity Only). The 
penetrance tables for Trait I and Trait II are presented. Cell 
values indicate penetrance level, or the probability of having 
the trait, given the corresponding multilocus genotype. For 
each of the two traits, a Mendelian recessive genetic model is 
used, in which the trait is penetrant only when two copies of 
the high risk (B) allele are present. The penetrance (x) is con-
strained by the desired overall disease prevalence to be sim-
ulated (0.001, 0.01, 0.05 or 0.15).
 (I)  
1A1A 1A1B 1B1B
0 0 x 
(II)  
2A2A 2A2B 2B2B
0 0 x BMC Bioinformatics 2006, 7:204 http://www.biomedcentral.com/1471-2105/7/204
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locus heterogeneity is also simulated, an even more suc-
cessful clustering would be one in which there are two or
more Trait II clusters, each of which has only those indi-
viduals who have a specific high-risk genotype (e.g., 2B2B
from Figure 12) and none that do not.
The first clustering method is Bayesian Classification
[39,52]. The corresponding AutoClass software is freely
available from Peter Cheeseman at the NASA Ames
Research Center. Bayesian Classification (BC) aims to find
the most probable clustering of data given the data and
the prior probabilities. In the case of genotypic data, prior
probabilities are based on genotype frequencies, which
for the purpose of the proposed data simulations are set
in accordance with Hardy-Weinberg equilibrium and
equal biallelic frequencies of 0.5. The most probable clus-
tering of data is determined from two posterior probabil-
ities. The first involves the probability that a particular
individual belongs to its 'assigned' cluster, or otherwise
stated as the probability of the individual's multilocus
genotype, conditional on it belonging to that cluster, with
its characteristic genotypes. The second posterior proba-
bility involves the probability of a cluster given its
assigned individuals, or otherwise stated as the probabil-
ity of the cluster's characteristic genotypes, conditional on
the multilocus genotypes of the individuals assigned to
that cluster.
In actuality, individuals are not 'assigned' to clusters in the
hard classification sense but instead in the fuzzy sense
they are temporarily assigned to the cluster to which they
have the greatest probability of belonging. Thus, each
individual has its own vector of probabilities of belonging
to each of the clusters. The assignment of individuals is
also not considered the most important result of the clus-
tering method. A ranked listing is produced of all loci in
the dataset with their corresponding normalized
"attribute influence" values (ranging between 0 and 1),
which provide a rough heuristic measure of relative influ-
ence of each locus in differentiating the classes from the
overall data set. Thus, emphasis is placed on the identifi-
cation of which attributes, or loci, are most important in
producing the clustering. This information that can then
Genetic Model THB (Trait Heterogeneity with Both Locus  Heterogeneity and Gene-Gene Interaction) Figure 14
Genetic Model THB (Trait Heterogeneity with Both 
Locus Heterogeneity and Gene-Gene Interaction). 
The penetrance tables for Trait I and Trait II are presented. 
Cell values indicate penetrance level, or the probability of 
having the trait, given the corresponding multilocus geno-
type. For Trait I, a locus heterogeneity model described by Li 
and Reich [49] is used, in which the trait is penetrant only 
when two copies of the high risk allele at one or both loci 
are present (in this case the B alleles for locus 2 and 3 are 
high risk). For Trait II, the ''diagonal'' genetic model first 
described by Frankel & Schork [50] and later by Li and Reich 
[49] is used. Two loci (2 and 3) are involved, each with two 
alleles (A and B), and the trait is penetrant only when exactly 
two copies of the high risk allele from either locus are 
present.
 (I)  
1A1A 1A1B 1B1B
2A2A 0 0 x 
2A2B 0 0 x 
2B2B x x x 
(II)  
 3A3A 3A3A 3A3A
4A4A 0 0 x 
4A4B 0 0.5x 0 
4B4B x 0 0  Genetic Model THG (Trait Heterogeneity with Gene-Gene  Interaction) Figure 13
Genetic Model THG (Trait Heterogeneity with 
Gene-Gene Interaction). The penetrance tables for Trait 
I and Trait II are presented. Cell values indicate penetrance 
level, or the probability of having the trait, given the corre-
sponding multilocus genotype. For Trait I, a Mendelian reces-
sive genetic model is used, in which the trait is penetrant 
only when two copies of the high risk (B) allele are present. 
For Trait II, the ''diagonal'' genetic model first described by 
Frankel & Schork [50] and later by Li and Reich [49] is used. 
Two loci (2 and 3) are involved, each with two alleles (A and 
B), and the trait is penetrant only when exactly two copies of 
the high risk allele from either locus are present.
 (I)  
1A1A 1A1B 1B1B
0 0 x 
(II)  
 2A2A 2A2B 2B2B
3A3A 0 0 x 
3A3B 0 0.5x 0 
3B3B x 0 0 BMC Bioinformatics 2006, 7:204 http://www.biomedcentral.com/1471-2105/7/204
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be used to more directly stratify affected (and/or unaf-
fected) individuals, for instance, by using the top n most
influential loci identified, and to enable meaningful inter-
pretation of the clustering result.
The second method is Hypergraph Clustering [40]. It has
been implemented in the hMETIS software, which is freely
available from George Karypis at the University of Minne-
sota. Hypergraph clustering seeks a partitioning of verti-
ces, such that intracluster relatedness meets a specified
threshold, while the weight of hyperedges cut by the par-
titioning is minimized. In this case, vertices represent sin-
gle locus genotypes, hyperedges represent association
rules, and hyperedge weights represent the strength of the
association rules. For instance, if a specific genotype at
one locus co-occurs with a specific genotype at another
locus, an association rule linking those two genotypes
would be created, and that rule would have a weight
equivalent to the proportion of individuals in the dataset
that had both of those genotypes. Thus, for our purposes,
association rules are multilocus genotype combinations
that are found in the dataset. The freely available LPminer
Hypothetical Clustering of a THO Dataset Figure 15
Hypothetical Clustering of a THO Dataset. (a) A small dataset that consistent Trait Heterogeneity Only (THO) genetic 
model (see Figure 11) is presented. All individuals with the high risk genotype (BB) at locus 1 have Trait I, and all individuals 
with the high risk genotype (BB) at locus 2 have Trait II. Some individuals have both high risk genotypes and, therefore, both 
traits. A successful clustering of this dataset might be one in which there are two clusters (b) and (c), such that one cluster con-
tains only individuals who have Trait I (b) and the other cluster contains only individuals who have Trait II (c).
 (a) 
    Locus       Trait
Indiv 1 2 3 4  5  6 7 8 9  10  1 2 
1  BB  AB AB AB  AB  AA AB BB AB BB X  
2 AB  BB  BB AB  BB  BB AB AB BB AB   X
3  BB BB AA AA  AB  AB AA AB BB AB X X
4 AB  BB  AB AB  AB  AB BB AB AA AB   X
5  BB  AB AA AB  AA  AB AA AB AA BB X
6  BB  AB AB AB  BB  BB AB AA AB AB X
7  BB BB BB BB  AB  AB AA AB BB AB XX
8 AB  BB  AB AB  AA  AA AB BB AB BB   X
9  BB  AA AB AB  BB  AB AB AA AB AB X  
10 AB  BB  AB BB  AB  AB BB AB AB AA   X
11 AA  BB  AA AA  AA  AB AA AB AB AB   X
12  BB  AB BB BB  AB  BB AB BB AA AB X  
13 AB  BB  AB AA  AB  AB BB AB AA AA   X 
14  BB  AA AB AB  BB  BB AB AA AB AB X  
15 AB  BB  BB BB  AB  AA AB BB AB AA   X 
(b) 
    Locus       Trait
Indiv 1 2 3 4  5  6 7 8 9  10  1 2 
1  BB  AB AB AB  AB  AA AB BB AB BB X  
3  BB BB AA AA  AB  AB AA AB BB AB X X
5  BB  AB AA AB  AA  AB AA AB AA BB X
6  BB  AB AB AB  BB  BB AB AA AB AB X
9  BB  AA AB AB  BB  AB AB AA AB AB X  
12  BB  AB BB BB  AB  BB AB BB AA AB X  
14  BB  AA AB AB  BB  BB AB AA AB AB X  
(c) 
    Locus       Trait
Indiv 1 2 3 4  5  6 7 8 9  10  1 2 
2 AB  BB  BB AB  BB  BB AB AB BB AB   X
4 AB  BB  AB AB  AB  AB BB AB AA AB   X
7  BB BB BB BB  AB  AB AA AB BB AB XX
8 AB  BB  AB AB  AA  AA AB BB AB BB   X
10 AB  BB  AB BB  AB  AB BB AB AB AA   X
11 AA  BB  AA AA  AA  AB AA AB AB AB   X
13 AB  BB  AB AA  AB  AB BB AB AA AA   X 
15 AB  BB  BB BB  AB  AA AB BB AB AA   X BMC Bioinformatics 2006, 7:204 http://www.biomedcentral.com/1471-2105/7/204
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program was used to generate the association rules [53].
LPminer searches the database for multilocus genotype
combinations that appear together with substantial fre-
quency (above a prespecified "support" percentage) and
outputs this info as a list of association rules. hMETIS
takes these association rules and uses them to create a
hypergraph in which single locus genotypes are vertices
and association rules dictate the presence and weight of
hyperedges. hMETIS creates a partition of the hypergraph
such that the weight of the removed hyperedges is mini-
mized. It achieves this by using a series of phases, some-
what analogous to the stages of a simulated annealing
algorithm, in an attempt to avoid making decisions which
are only locally (not globally) optimal.
This process results in a partitioning (or clustering) of the
genotypes in a dataset. If a single dataset was being ana-
lyzed, this information by itself could be sufficiently help-
ful since it would provide information about which
multilocus genotypes appear with such frequency that
they characterize groups of individuals. Individuals could
be directly stratified using such multilocus combinations
(similar to the way attribute influence values in the Baye-
sian Classification method could be used). However, for
the purpose of comparing the results of Hypergraph Parti-
tioning to those of the other two methods, which produce
clusters, or partitions, of individuals (not genotypes),
such a partitioning of individuals still needed to be cre-
ated. Since a given individual could have more than one
of the multilocus genotypes specified by different hyper-
edges in the final partitioning, the partitioning of individ-
uals was not entirely straightforward. Thus, a heuristic was
devised such that each individual would be assigned to
the partition, or cluster, for which it had the highest per-
centage of matching genotypes (Figure 16). More specifi-
cally, for each cluster, the number of loci represented by
one or more genotypes in that cluster was determined
(Lc). Then, for each individual, for each cluster, the
Example of Post-processing of Hypergraph Clustering Result Figure 16
Example of Post-processing of Hypergraph Clustering Result. Hypergraph clustering produces a clustering of geno-
types, instead of individuals. Thus, a clustering of individuals must be induced from this clustering of genotypes. As described in 
the text, an individual in assigned to the cluster for which it has the highest percentage of matching genotypes. Given the data-
set presented in Figure 15(a) and a clustering of genotypes that is presented here (a), a clustering of individuals can be induced 
(b). For each individual (row), the percentage of matching genotypes that is highlighted indicates to which cluster the individual 
becomes assigned. Notice that for individual 5, there is a tie between the percentage of matching genotypes for clusters 1 and 
3. In such cases, we arbitrarily assign the individual to the lower numbered cluster. Since cluster 3 does not contain any high-
risk genotypes, it does not facilitate the goal of creating a clustering that maps to the simulated trait heterogeneity, and in the 
case of individual 12, it ends up capturing an individual who would preferably be clustered in cluster 1.
 (a) 
Cluster 1 Cluster  2 Cluster  3
1B1B   2B2B   7A7B 
3A3B     9A9A 
(b) 
    Locus       
Percentage 
of Matching 
Genotypes 
by Cluster 
Indiv 1 2 3 4  5  6 7 8 9  10 1  2  3 
1  BB AB AB AB AB  AA AB BB AB BB 100  0 50 
2 AB  BB BB AB BB BB AB AB BB AB 0  100  50 
3  BB BB AA AA AB AB AA AB BB AB 50  100  0 
4 AB  BB AB AB AB AB BB AB AA AB 50  100  50 
5  BB AB AA AB AA  AB AA AB AA BB 50*  0 50 
6  BB AB AB AB BB  BB AB AA AB AB 100  0 50 
7  BB BB BB BB AB AB AA AB BB AB 50  100  0 
8 AB  BB AB AB AA AA AB BB AB BB 50  100  50 
9  BB AA AB AB BB  AB AB AA AB AB 100  0 50 
10 AB  BB AB BB AB AB BB AB AB AA 50  100  0 
11 AA  BB AA AA AA AB AA AB AB AB 0  100  0 
12  BB AB BB BB AB  BB AB BB AA AB 50  0  100**
13 AB  BB AB AA AB AB BB AB AA AA 50  100  0 
14  BB AA AB AB BB  BB AB AA AB AB 100  0 50 
15 AB  BB BB BB AB AA AB BB AB AA 0  100  50 BMC Bioinformatics 2006, 7:204 http://www.biomedcentral.com/1471-2105/7/204
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Example of k-Modes Clustering Figure 17
Example of k-Modes Clustering. In this example, the same dataset presented in Figure 15 is used to demonstrate the dif-
ferent steps involved the k-modes clustering algorithm. In this example, k was chosen to be 4, such that four clusters will ini-
tially be formed. (a) The cluster centroids are seeded by randomly selecting the genotypes of actual individuals in the dataset. 
The number in parentheses beside the cluster number is the individual used to seed that cluster. (b) Individuals are then com-
pared to each of the cluster centroids, and the number of nonmatching genotypes between each cluster centroid and that indi-
vidual are recorded. The individual is then assigned to the cluster for which it had the fewest number of nonmatching 
genotypes (in bold). (c) The next step is to update the cluster centroids based on the individuals now assigned to the clusters. 
The mode genotype among individuals assigned to a cluster becomes the centroid genotype at that locus. Genotypes that 
changed from the initialization to the update are shown in bold. (d) After the centroids are updated, the individuals are reeval-
uated as to which cluster they most closely resemble and are assigned to that cluster. Only cluster 4 was assigned to a different 
cluster than it was previously. Steps (c) and (d) are repeated until no genotypes are changed in any cluster centroid and no indi-
viduals' cluster assignments are changed.
 (a) 
     L o c u s       
Cluster 1 2 3 4  5  6 7 8 9  10 
1 (1)  BB AB AB AB  AB  AA AB BB AB BB 
2 (5)  BB AB AA AB  AA  AB AA AB AA BB 
3 (12)  BB AB BB BB  AB  BB AB BB AA AB 
4 (15)  AB BB BB BB  AB  AA AB BB AB AA 
(b) 
      Locus        
 Cluster 
Distance 
  
Indiv  1  2 3  4  5 6  7  8 9 10 1 2 3 4 
1  BB AB  AB AB AB  AA AB BB  AB BB  0  6 5 5 
2  AB BB  BB AB BB  BB AB AB  BB AB  8  8  6  6 
3  BB BB  AA AA AB  AB AA AB  BB AB  8  5  7 8 
4  AB BB  AB AB AB  AB BB AB  AA AB  7  6  7 7 
5  BB AB  AA AB AA  AB AA AB  AA BB  6  0  5 10 
6  BB AB  AB AB BB  BB AB AA  AB AB  4  7 5 8 
7  BB BB  BB BB AB  AB AA AB  BB AB  8  6  5  6 
8  AB BB  AB AB AA  AA AB BB  AB BB  4  7 8 4 
9  BB AA  AB AB BB  AB AB AA  AB AB  5  7 8 8 
10  AB BB  AB BB AB  AB BB AB  AB AA  7  8  8  4 
11  AA BB  AA AA AA  AB AA AB  AB AB  9  5  9 8 
12  BB AB  BB BB AB  BB AB BB  AA AB  5  7  0  5 
13  AB BB  AB AA AB  AB BB AB  AA AA  8  7  8  6 
14  BB AA  AB AB BB  BB AB AA  AB AB  5  7 6 8 
15  AB BB  BB BB AB  AA AB BB  AB AA  5 10 5  0 
(c) 
     L o c u s       
Cluster 1 2 3 4  5  6 7 8 9  10 
1   BB  AA  AB AB BB  AA AB AA  AB  AB 
2   BB  BB  AA  AA  AA  AB AA AB AA AB 
3   BB  BB  BB  BB AB BB  AB  AB BB AB 
4 AB BB AB  BB AB AB BB AB AB AA 
(d) 
      Locus        
 Cluster 
Distance 
  
Indiv  1  2 3  4  5 6  7  8 9 10 1 2 3 4 
1  BB AB  AB AB AB  AA AB BB  AB BB  4  9 7 7 
2  AB BB  BB AB BB  BB AB AB  BB AB  6  7  3  7 
3  BB BB  AA AA AB  AB AA AB  BB AB  8  3  4 6 
4  AB BB  AB AB AB  AB BB AB  AA AB  7  6  6  3 
5  BB AB  AA AB AA  AB AA AB  AA BB  8  3  8 8 
6  BB AB  AB AB BB  BB AB AA  AB AB  2  8 6 8 
7  BB BB  BB BB AB  AB AA AB  BB AB  8  4  2  5 
8  AB BB  AB AB AA  AA AB BB  AB BB  5  8 8 6 
9  BB AA  AB AB BB  AB AB AA  AB AB  1  7 7 7 
10  AB BB  AB BB AB  AB BB AB  AB AA  8  7  6  0 
11  AA BB  AA AA AA  AB AA AB  AB AB  8  2  7 6 
12  BB AB  BB BB AB  BB AB BB  AA AB  7  7  3  8 
13  AB BB  AB AA AB  AB BB AB  AA AA  9  5  7  2 
14  BB AA  AB AB BB  BB AB AA  AB AB  1  8 6 8 
15  AB BB  BB BB AB  AA AB BB  AB AA  7  9  5  4 BMC Bioinformatics 2006, 7:204 http://www.biomedcentral.com/1471-2105/7/204
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number of matching genotypes between the cluster and
the individual (Mic) was divided by Lc, producing a vector
of similarity percentages per individual, similar to the vec-
tor of probabilities used by the Bayesian Classification
and Fuzzy k-Modes Clustering methods. Each individual
was then assigned to the cluster with which it had the
greatest similarity.
The third clustering method is Fuzzy k-Modes Clustering
[41]. k-Modes is a trivial extension of the popular k-means
algorithm to categorical data. In both methods, cluster
centroids can be initialized at random or by one of many
seeding strategies [44], and individuals are assigned to
their nearest cluster centroids. Then, cluster centroids are
reevaluated based on their newly assigned individuals. For
the k-means algorithm, the centroid is calculated as the
mean vector of genotypes across individuals. However, for
nominal data, such means are not necessarily meaningful,
and the k-modes algorithm instead determines the cen-
troid as the mode vector of genotypes across individuals.
Genotypes are encoded nominally (not ordinally), such
that no two genotypes are considered 'closer' than another
two, and the 'distance' between an individual and a cen-
troid is calculated as the cumulative number of non-
matching genotypes across all loci. After cluster centroids
are reevaluated, individuals are again assigned to their
nearest centroids, and this process is repeated until the
assignment of individuals to clusters does not change. Fig-
ure 17 demonstrates the first steps of the k-modes cluster-
ing, using the same dataset presented in Figures 15 and
16. The straightforward algorithm was developed in the
C++ language. The number of clusters (k) was prespecified
to be 2, 3, 4, 5 or 6. All five possible k were run for each
dataset. Each cluster centroid was initially set to the values
of a randomly selected individual in the dataset being
analyzed. Both a 'fuzzy' and a 'hard' version of the k-
modes algorithm were implemented and tested, and
while their results on test datasets were comparable, the
fuzzy version did perform slightly better and provided
more information, which could be used for interpretation
of results. Thus, the fuzzy version was chosen for use in
these analyses.
Statistical analysis
Comparison of clustering methods
Each clustering method has its own metric(s) for evaluat-
ing the "goodness" of a clustering of data. Since these
methods are being tested on simulated data, classification
error of a given clustering can be calculated as the number
of misclassified individuals divided by the total number
of individuals. However, simple classification error has its
disadvantages. Firstly, in cases such as this where there is
overlap between the known classes, the researcher must
make an arbitrary decision as to when individuals who
have been simulated to have both traits, not just one or
the other, are considered to be misclassified. The decision
about error is equally arbitrary when the number of result-
ing clusters is greater than the number of known classes.
For instance, if the individuals belonging to one class were
divided into two classes by the clustering algorithm, calcu-
lating classification error would require either (1) that
none of those individuals be considered incorrectly classi-
fied, since they are all in homogenous clusters, or else (2)
that all individuals from one of those clusters be consid-
ered misclassified. Neither choice seems to satisfactorily
capture the "goodness" of the clustering result. Subse-
quently, it is not advisable to compare the classification
error of two clustering results for which the number of
clusters differs.
It is for these reasons alternative cluster recovery metrics
were investigated. The Hubert-Arabie Adjusted Rand
Index (ARIHA) addresses the concerns raised by classifica-
tion error and was, therefore, chosen to evaluate the good-
ness of clustering results from the three clustering
methods being compared [42]. Calculation of the ARIHA
involves determining (1) whether pairs of individuals,
who were simulated to have the same trait, are clustered
together or apart and (2) whether pairs of individuals,
who do not have the same trait, are clustered together or
apart. The ARIHA is robust with regard to the number of
individuals to cluster, the number of resulting clusters,
and the relative size of those clusters [54]. It is, however,
sensitive to the degree of class overlap, which is desirable
since it will penalize more for good clusterings that occur
by chance than classification error would. When interpret-
ing ARIHA values, 0.90 and greater can be considered excel-
lent recovery, 0.80 and greater is good recovery, 0.65 and
greater reflects moderate recovery, and less than 0.65 indi-
cates poor recovery. These values were derived from
empirical studies showing observations cut at the 95th,
90th, 85th and 80th percentiles corresponded to ARIHA
values of 0.86, 0.77, 0.67 and 0.60 respectively [54].
The ARIHA was used as the gold standard measure to com-
pare the performance of the three clustering methods.
Three categorical variables were created that could be
tested using the nonparametric chi-square test of inde-
pendence. The ARIHA values were discretized into a 1 or 0
depending on whether they met or exceeded the cutoff
values for excellent, good and moderate cluster recovery,
as described above. A chi-square test of independence was
performed testing the null hypothesis that the number of
clusterings achieving a certain ARIHA value was independ-
ent of the clustering method. Five percent was chosen as
the significance level (alpha). An evaluation was per-
formed of whether one method significantly outper-
formed the others and whether that method performed
satisfactorily accordingly to the ARIHA.BMC Bioinformatics 2006, 7:204 http://www.biomedcentral.com/1471-2105/7/204
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Applicability to real data
As a reminder, the ultimate goal of this research is to find
a clustering method that works well at uncovering trait
heterogeneity in real genotypic data. Unlike for the cur-
rent simulation study, for real data to which clusters indi-
viduals belong is not known a priori, otherwise the
clustering would not be necessary. Indeed, it is the goal of
clustering to uncover natural clusters or partitions of data
using the method-specific "goodness" metric as a guide.
In preparation for application of a clustering method to
real data, after choosing the superior method, that
method's internal clustering metrics were analyzed using
permutation testing to determine how good a proxy they
are for ARIHA.
The Bayesian Classification method produces two internal
clustering metrics for each resulting cluster, or class: (1)
class strength, and (2) cross-class entropy. Class strength
is a heuristic measure of how strongly each class predicts
"its" instances and is reported as the log of class strength.
Cross-class entropy is a measure of how strongly the class
probability distribution function differs from that of the
dataset as a whole. Because each metric is reported per
resulting cluster, or class, the average metric value across
clusters was calculated and utilized for evaluating cluster
fitness.
The ratio of one hundred permuted datasets per simulated
dataset was chosen, which should result in a reasonable
approximation of the null distribution but would not put
unreasonable strain on resources and time [55]. Geno-
types were permuted within loci across individuals, such
that the overall frequency of genotypes at any one locus
was unchanged, but the frequency of multilocus geno-
types was altered at random. This created a null sample in
which the frequency of multilocus genotypes was no
longer associated with trait status except by chance. The
empirically-determined superior clustering method was
applied to each permuted data set and both the internal
clustering metric values and the ARIHA were determined.
For each set of 100 permuted data sets, the significance of
each of the simulated dataset results was determined
based on whether they exceeded the values at the signifi-
cance level in the corresponding null distribution. Ten
percent was chosen as the acceptable Type I error rate
since these methods serve as a means of data exploration
to be followed by more rigorous, supervised analyses on
individual clusters of the data. However, the more con-
ventional levels of 0.05 and 0.01 were also evaluated.
Finally, the ability of permutation testing to preserve an
acceptable Type I (false positive) error rate was evaluated
at the three specified significance levels. A false positive
was defined as a clustering result which had a p-value
according to at either of the internal clustering metrics
that was significant but had a p-value according to ARIHA
that was not significant. The Type II (false negative) error
rate was evaluated at the same alpha levels to determine
the sensitivity for detecting trait heterogeneity when it is
present. A false negative was defined as a clustering result
which had a p-value that was not significant according to
both of the internal clustering metrics but had a p-value
that was significant according to ARIHA.
Abbrevations
ARIHA Hubert-Arabie Adjusted Rand Index
THO Trait Heterogeneity Only
THL Trait Heterogeneity with Locus Heterogeneity
THG Trait Heterogeneity with Gene-Gene Interaction
THB Trait Heterogeneity with Both Locus Heterogeneity
and Gene-Gene Interaction
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